Pipeline

We are advancing a robust pipeline of innovative Class2 Medical Devices 510K designed to address significant unmet medical needs across three key areas: mitigating cancer treatment toxicities associated to chemo and radiotherapy improving women’s health, with a focus on menopause and breast cancer survivors; and preventing and treating human microbiome dysbiosis, particularly in conditions involving host-immune system alterations.

Alternative adaptation to cosmetic regulatory path in given countries.

Our clinical research is driven by a commitment to develop safe, effective, and consumer oriented solutions that enhance patient outcomes and overall quality of life.